Live from the NIH registry
Studies recruiting near Shreveport right now
Top 25 of 161 recruiting studies, sorted by proximity — each links to its official registry page
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Louisiana State University Health Sciences Shreveport ( Site 0053) — Shreveport, Louisiana (4.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Shreveport, LA — Shreveport, Louisiana (4.9 mi)
· Sponsor: Mediar Therapeutics
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Overton Brooks V.A. Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Novo Nordisk A/S
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1048 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Immunovant Sciences GmbH
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
Louisiana State University Health Sciences Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: St. Jude Children's Research Hospital
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Christus Health Highlands — Shreveport, Louisiana (4.9 mi)
· Sponsor: Paradigm Health
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
Willis Knighton Cancer Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Natera, Inc.
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Kailera
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: NRG Oncology
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Grace Research, LLC-Shreveport-64616 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Boehringer Ingelheim
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Medtronic
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: SWOG Cancer Research Network
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
LSU Health Sciences Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Jazz Pharmaceuticals
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Louisiana Research Center, LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Eccogene
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Ochsner LSU Health Saint Mary's Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: National Cancer Institute (NCI)
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
Acute Kidney Injury
N/A
Interventional 339 participants sought
Ochsner LSU Health Academic Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: SeaStar Medical
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Trials365 LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Daiichi Sankyo
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
LSU Health Shreveport Clinical Trials Office — Shreveport, Louisiana (4.9 mi)
· Sponsor: Pfizer
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Louisiana State University Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Mercy Health Ohio
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Willis Knighton Health — Shreveport, Louisiana (4.9 mi)
· Sponsor: HistoSonics, Inc.